CRNX
Price
$31.12
Change
+$0.50 (+1.63%)
Updated
Apr 2, 02:52 PM (EDT)
Capitalization
2.85B
36 days until earnings call
RNA
Price
$29.76
Change
+$3.02 (+11.29%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
3.21B
41 days until earnings call
Ad is loading...

CRNX vs RNA

Header iconCRNX vs RNA Comparison
Open Charts CRNX vs RNABanner chart's image
Crinetics Pharmaceuticals
Price$31.12
Change+$0.50 (+1.63%)
Volume$816
Capitalization2.85B
Avidity Biosciences
Price$29.76
Change+$3.02 (+11.29%)
Volume$21.25K
Capitalization3.21B
CRNX vs RNA Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. RNA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and RNA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CRNX: $30.62 vs. RNA: $26.74)
Brand notoriety: CRNX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 224% vs. RNA: 174%
Market capitalization -- CRNX: $2.85B vs. RNA: $3.21B
CRNX [@Biotechnology] is valued at $2.85B. RNA’s [@Biotechnology] market capitalization is $3.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and RNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • RNA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than RNA.

Price Growth

CRNX (@Biotechnology) experienced а -12.69% price change this week, while RNA (@Biotechnology) price change was -16.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

CRNX is expected to report earnings on May 08, 2025.

RNA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.21B) has a higher market cap than CRNX($2.85B). RNA YTD gains are higher at: -8.047 vs. CRNX (-40.113). CRNX has higher annual earnings (EBITDA): -336.07M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. CRNX (1.35B). RNA has less debt than CRNX: RNA (6.8M) vs CRNX (51.7M). RNA has higher revenues than CRNX: RNA (10.9M) vs CRNX (1.04M).
CRNXRNACRNX / RNA
Capitalization2.85B3.21B89%
EBITDA-336.07M-376.16M89%
Gain YTD-40.113-8.047499%
P/E RatioN/AN/A-
Revenue1.04M10.9M10%
Total Cash1.35B1.5B90%
Total Debt51.7M6.8M760%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXRNA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEUCX52.590.38
+0.73%
American Funds Europacific Growth 529C
ICEQX20.84N/A
N/A
Macquarie Core Equity Fund Class R6
LMBCX10.37N/A
N/A
Franklin U.S. Small Cap Equity C
PLARX10.42N/A
N/A
Principal SmallCap Value II R5
INDIX16.69N/A
N/A
ALPS/Kotak India ESG I

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ELVN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-8.71%
ELVN - CRNX
51%
Loosely correlated
-4.07%
TRDA - CRNX
50%
Loosely correlated
-3.10%
INZY - CRNX
48%
Loosely correlated
-4.40%
IDYA - CRNX
48%
Loosely correlated
-9.83%
IGMS - CRNX
47%
Loosely correlated
N/A
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with DYN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
-9.42%
DYN - RNA
45%
Loosely correlated
-11.76%
ACLX - RNA
44%
Loosely correlated
-7.47%
CRNX - RNA
44%
Loosely correlated
-8.71%
RYTM - RNA
43%
Loosely correlated
-5.61%
RVMD - RNA
43%
Loosely correlated
-4.92%
More